Now available, Taro-Fingolimod, a generic alternative to Gilenya®
Given the unique requirements of Fingolimod, Taro will be launching the TaroCares® Program to support our product and minimize any disruption to Patients, Physicians, or Pharmacists.
To enroll a patient for support or to schedule first-dose observation please call 1.833.618.0571
Release Date:
Monday, November 4, 2019
![Health Products](/sites/all/themes/taro_canada/images/health-product.jpg)
![WCAG 2.0](/sites/all/themes/taro_canada/images/w3c.jpg)